Skip to Main Content

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

Conditions

Addictive Behaviors | Mental Health & Behavioral Research | Obesity & Weight Control

Phase IV

What is the purpose of this trial?

Brief Summary:

This study will test the effectiveness and relative efficacy of behavioral and pharmacologic treatments, alone and in combination, for the treatment of binge eating disorder (BED) in patients with obesity. This is an acute treatment comparing behavioral weight loss alone or in combination with naltrexone/bupropion medication.

  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDKD)
  • Start Date
    04/25/2018
  • End Date
    09/29/2024
Trial Image

For more information about this study, contact:

Janet Lydecker

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    03/13/2020
  • Study HIC
    #2000021769